Products for Research Use Only
RegisterLogin

IBL-302

CAT: 0013-GTR19235125-01Size: 25 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19235125-01Size:25 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
IBL-302 (AMU302) is an orally bioavailable dual PIM and PI3K/AKT/mTOR pathway inhibitor. It demonstrates efficacy in breast cancer and neuroblastoma models, overcoming trastuzumab resistance in vivo and synergizing with chemotherapeutics like cisplatin in vitro.
CAS Number
1414455-21-2
Field of Research
Epigenetics & Chromatin, Signal Transduction
Smiles
CC=1C2=C3C (C=4SC (=CC4) CNC (=O) C=5C=C (S (=O) (=O) NC6=CC (C1S3) =CN=C6OC) C=CC5F) =NC=N2
Molecular Formula
C25H18FN5O4S3
Molecular Weight
567.64
Storage Conditions
-20°C
Notes
For research use only.

Related Products

CatalogName
GTR19201024-01AND-302
GTR19174191-01RU-302
GTR19202956UBP 302
GTR19250154-01SR-302
GTR19234137-01KP-302
GTR19144618-01JKC 302
GTR19276867-01CRBN ligand-302
GTR19274495-01Antibacterial agent 302
GTR19196143-01XC-302 free base
GTR18315437CLDN6 Reference Antibody (IM-302)

Alternative Products

CatalogName
BA6400-1IBL-302
sc-59076CD45RC (IBL-8)
sc-65353MARCO (IBL-12)
HY-120240AND-302
sc-65375Siglec-1 (IBL-13)
B6942-5UBP 302
A3872-50TH-302
BA9036-5.1RU-302
HY-150307-01KP-302
023-50JKC-302

Popular Products